Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

TAVR: Long-term outcomes | Valve-in-valve TAVR after one year | To delay or not to delay

News You Need to Know Today
TAVR: Long-term outcomes | Valve-in-valve TAVR after one year | To delay or not to delay
Tuesday, July 13, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: TAVR

TAVR still comparable to surgery after 8 years

When it comes to the risk of structural valve deterioration, however, one treatment option clearly outperforms the other. 

READ MORE >
Old doctor
Share on Twitter Share on Facebook Share on Linkedin

TAVR still comparable to surgery after 8 years

Share on Twitter Share on Facebook Share on Linkedin
Old doctor
When it comes to the risk of structural valve deterioration, however, one treatment option clearly outperforms the other. 
READ MORE >

Permanent pacemaker implantation before or after TAVR linked to worse outcomes

Researchers tracked more than 49,000 TAVR patients, sharing their findings in Heart Rhythm. 

READ MORE >
IVUS guidance during DES implantation boosts long-term outcomes in new study
Share on Twitter Share on Facebook Share on Linkedin

Permanent pacemaker implantation before or after TAVR linked to worse outcomes

Share on Twitter Share on Facebook Share on Linkedin
IVUS guidance during DES implantation boosts long-term outcomes in new study
Researchers tracked more than 49,000 TAVR patients, sharing their findings in Heart Rhythm. 
READ MORE >

Valve-in-valve TAVR outcomes ‘excellent’ after one year

Moderate to severe aortic regurgitation was seen in 0.9% of patients after 30 days and 1.3% after one year.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Valve-in-valve TAVR outcomes ‘excellent’ after one year

Share on Twitter Share on Facebook Share on Linkedin
Moderate to severe aortic regurgitation was seen in 0.9% of patients after 30 days and 1.3% after one year.
READ MORE >

TAVR safe for patients with inflammatory bowel disease

Patients with Crohn’s disease and ulcerative colitis can safely undergo TAVR, researchers at the Cleveland Clinic have confirmed in a new analysis.

READ MORE >
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Share on Twitter Share on Facebook Share on Linkedin

TAVR safe for patients with inflammatory bowel disease

Share on Twitter Share on Facebook Share on Linkedin
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Patients with Crohn’s disease and ulcerative colitis can safely undergo TAVR, researchers at the Cleveland Clinic have confirmed in a new analysis.
READ MORE >

Florida hospital celebrates 100th TAVR procedure

The procedure, like the hospital's first 99 TAVR cases, was a success. 

READ MORE >
heart.png
Share on Twitter Share on Facebook Share on Linkedin

Florida hospital celebrates 100th TAVR procedure

Share on Twitter Share on Facebook Share on Linkedin
heart.png
The procedure, like the hospital's first 99 TAVR cases, was a success. 
READ MORE >

How predilation affects TAVR outcomes for low-risk patients

The new study, published in Circulation: Cardiovascular Interventions, included data from nearly 500 TAVR patients.

READ MORE >
Doctor patient
Share on Twitter Share on Facebook Share on Linkedin

How predilation affects TAVR outcomes for low-risk patients

Share on Twitter Share on Facebook Share on Linkedin
Doctor patient
The new study, published in Circulation: Cardiovascular Interventions, included data from nearly 500 TAVR patients.
READ MORE >

To delay or not to delay? When treating TAVR patients during the pandemic, heart teams faced big decisions

Delaying TAVR for six months can have a negative effect on patient outcomes. During the pandemic, however, there were certain times when a delay was safer than completing the procedure. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

To delay or not to delay? When treating TAVR patients during the pandemic, heart teams faced big decisions

Share on Twitter Share on Facebook Share on Linkedin
Delaying TAVR for six months can have a negative effect on patient outcomes. During the pandemic, however, there were certain times when a delay was safer than completing the procedure. 
READ MORE >

Presenting with additional chronic conditions can make a big impact on TAVR outcomes

Hypertension, for instance, can increase an individual's risk of post-TAVR hospitalization or mortality, according to a new analysis of more than 350 high-risk patients.  

READ MORE >
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Share on Twitter Share on Facebook Share on Linkedin

Presenting with additional chronic conditions can make a big impact on TAVR outcomes

Share on Twitter Share on Facebook Share on Linkedin
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Hypertension, for instance, can increase an individual's risk of post-TAVR hospitalization or mortality, according to a new analysis of more than 350 high-risk patients.  
READ MORE >

TAVR, SAVR both beneficial for patients with low-gradient aortic stenosis

The new meta-analysis included data from 32 studies. 

READ MORE >
Doctor patient
Share on Twitter Share on Facebook Share on Linkedin

TAVR, SAVR both beneficial for patients with low-gradient aortic stenosis

Share on Twitter Share on Facebook Share on Linkedin
Doctor patient
The new meta-analysis included data from 32 studies. 
READ MORE >

13% of TAVR patients develop acute kidney injury, increasing their risk of in-hospital mortality

Chronic kidney disease, congestive heart failure and liver disease are just some of the comorbidities associated with a greater risk of AKI. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

13% of TAVR patients develop acute kidney injury, increasing their risk of in-hospital mortality

Share on Twitter Share on Facebook Share on Linkedin
Chronic kidney disease, congestive heart failure and liver disease are just some of the comorbidities associated with a greater risk of AKI. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

FDA-approved valve makes US debut | Reviewing CRT 2026 | First TAVR of its kind uses crushed stent | 20-year PFO closure data
Meet the CVB 40 Under 40 | Another win for Wegovy | Key benefits of cardiovascular IT systems | New tirzepatide data | AI & IVUS
Top 10 most popular cardiology video interviews this past month
Week in Review: A historic TAVR approval | Death sentence confirmed for patient-killing nurse | Insulin delivery pods recalled
CMS targets cardiologists | AI turns wearable data into insights | Heart failure after PCI | Prior authorization reducing access
FDA clears next-gen insulin pump | Key issues in EP | New-look valve makes US debut | The benefits of morning exercise
New PE guidelines | FDA clears 'world's smallest camera' | Medtronic's $550M acquisition | J&J launches 3 stroke devices

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …16
    • Page 17
    • Page 18
    • Page 19
    • Current page 20
    • Page 21
    • Page 22
    • Page 23
    • Page 24 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme